Literature DB >> 3884018

Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. Preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes.

A Yamada, P L Cohen, J B Winfield.   

Abstract

The relative specificity of systemic lupus erythematosus antilymphocyte antibodies for T cell subsets bearing the OKT4, OKT8, or autologous erythrocyte rosette (A-RFC) markers was examined in complement-dependent microcytotoxicity assays and by indirect immunofluorescence. Target cells included normal OKT4+ or OKT8+ T cell clones established from mitogen-activated blasts, resting or phytohemagglutinin-activated peripheral T cells highly enriched for OKT4+ cells or OKT8+ cells, and A-RFC+ and A-RFC- populations. In the majority of sera, cytotoxicity for T4+ cells was greater than that for T8+ cells regardless of cellular activation status. Overall cytotoxicity was considerably higher for activated cells, however, especially when warm assay temperatures were used. A-RFC+ targets were more reactive than nonrosetting T cells, and this was associated with strikingly higher relative fluorescence intensity of IgM staining. Despite these consistent differences in relative cytotoxicity or staining, antibody titers against all cell types were strongly correlated in individual sera. Absorption experiments failed to demonstrate distinct antibody specificities for T4+ and A-RFC+ cells. These data suggest that the major determinant of cytotoxic reactivity may be a single or limited number of surface antigens common to all T cells. Superimposed on this dominant system(s) is a special reactivity with certain distinct subsets and with activated T cells generally.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884018     DOI: 10.1002/art.1780280305

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Anti-lymphocyte autoantibodies in systemic lupus erythematosus.

Authors:  J B Winfield; P D Fernsten; J K Czyzyk
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

2.  Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation.

Authors:  Rosa Catera; Yun Liu; Chao Gao; Xiao-Jie Yan; Amanda Magli; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Charles C Chu; Ten Feizi; Kostas Stamatopoulos; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2017-01-12       Impact factor: 6.354

3.  Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.

Authors:  P T Donaldson; M J Hussain; G Mieli-Vergani; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitro.

Authors:  P W Peake; J D Greenstein; V Timmermans; L Gavrilovic; J A Charlesworth
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

Review 5.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia.

Authors:  M Noguchi; M Iwamori; T Hirano; S Kobayashi; H Hashimoto; S Hirose; Y Nagai
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

Review 7.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

Review 8.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

9.  Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus.

Authors:  T Mimura; P Fernsten; W Jarjour; J B Winfield
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.